Gilead Sciences Partners With White House for Early Cancer Detection Program "Biden Cancer Moonshot"
Gilead Sciences Partners With White House for Early Cancer Detection Program "Biden Cancer Moonshot"
NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / Gilead Sciences:
马萨诸塞州北安普敦/ACCESSWIRE/2024 年 5 月 28 日/吉利德科学：
In an effort to advance access to cancer prevention and early detection among U.S. workers, the Biden Cancer Moonshot recently announced a series of actions that organizations are taking to improve access and use of cancer screenings. We're proud to be included on the list for our commitment to help increase screening rates among employees through personalized outreach.
为了促进美国工人获得癌症预防和早期发现的机会，拜登癌症月球组织最近宣布了一系列行动，各组织正在采取这些行动，以改善癌症筛查的可及性和使用率。我们很荣幸能被列入名单，以表彰我们致力于通过个性化宣传帮助提高员工的筛选率。
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead Sciences, Inc. 是一家以研究为基础的生物制药公司，在医疗需求未得到满足的领域发现、开发和商业化创新药物。该公司致力于改变和简化对世界各地患有危及生命的疾病患者的护理。吉利德在全球超过35个国家开展业务，总部位于加利福尼亚州福斯特城。
Originally published by Gilead Sciences
最初由吉利德科学出版
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
在 3blmedia.com 上查看吉利德科学提供的更多多媒体和更多 ESG 故事。
Contact Info:
联系信息：
Spokesperson: Gilead Sciences
发言人：吉利德科学
SOURCE: Gilead Sciences
来源：吉利德科学